Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
Clinical trial NCT03426891 · COMPLETED
Trial details
- NCT number
- NCT03426891
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2021-10-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.